Full Text View
Tabular View
Study Results
Related Studies
Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Proteinase Inhibitor)
This study has been completed.
Study NCT00396006   Information provided by Baxter Healthcare Corporation

First Received on November 3, 2006.   Last Updated on March 3, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial